Immunoprecise Antibodies Ltd.
13F holders, Q3 2024 (September 30)18holders −1
1new positions
2sold out
1famous investor
$0.64avg. 13F price*
At the end of Q3 2024, 18 institutions reported holding Immunoprecise Antibodies Ltd. in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were Ingalls & Snyder LLC ($996K), Renaissance Technologies ($39K) and Bank of Montreal ($37K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Immunoprecise Antibodies Ltd.
- CUSIP
- 45257F200
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 2 | $17K |
All 13F filers, Q2 2024 → Q3 2024: 272,512 shares bought and 31,581 shares sold, net +240,931 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Ingalls & Snyder LLC | 0.04% | Add +20.3% | 1,558,892 | $996K |
| Renaissance Technologies | 0.00% | Reduce -5.7% | 60,300 | $39K |
| Bank of Montreal | 0.00% | Add +3.5% | 57,807 | $37K |
| Northern Trust Corp. | 0.00% | No change | 50,730 | $32K |
| Cibc World Market Inc. | 0.00% | No change | 41,200 | $26K |
| Gradient Capital Advisors, LLC | 0.01% | No change | 26,808 | $17K |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -2.8% | 26,273 | $17K |
| Geode Capital Management, LLC | 0.00% | No change | 17,484 | $11K |
| XTX Topco Ltd | 0.00% | Add +23.5% | 15,675 | $10K |
| Rathbones Group PLC | 0.00% | No change | 14,000 | $9K |
| Morgan Stanley | 0.00% | Add +19.0% | 12,533 | $8K |
| Mariner, LLC | 0.00% | No change | 10,000 | $6K |
| Bank of America Corp. | 0.00% | New | 2,000 | $1K |
| National Bank of Canada | 0.00% | Add +8.5% | 1,671 | $1K |
| West Paces Advisors Inc. | 0.00% | No change | 1,665 | $1K |
| Group One Trading LLC | 0.00% | Reduce -97.5% | 61 | $39 |
| Citigroup Inc. | 0.00% | No change | 7 | $4 |
| Simplex Trading, LLC | 0.00% | Reduce -98.7% | 100 | $0 |
"% of holder's portfolio" is IMMUNOPRECISE ANTIBODIES LTD's weight in each manager's 13F, not the share of Immunoprecise Antibodies Ltd. the manager owns.